ATE311450T1 - BIOMARKERS AND TARGETS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF PROSTATE CANCER - Google Patents

BIOMARKERS AND TARGETS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF PROSTATE CANCER

Info

Publication number
ATE311450T1
ATE311450T1 AT96926195T AT96926195T ATE311450T1 AT E311450 T1 ATE311450 T1 AT E311450T1 AT 96926195 T AT96926195 T AT 96926195T AT 96926195 T AT96926195 T AT 96926195T AT E311450 T1 ATE311450 T1 AT E311450T1
Authority
AT
Austria
Prior art keywords
biomarkers
prognosis
targets
diagnosis
management
Prior art date
Application number
AT96926195T
Other languages
German (de)
Inventor
Robert Veltri
S Mark O'hara
Gang An
David Ralph
Original Assignee
Urocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urocor Inc filed Critical Urocor Inc
Priority claimed from PCT/US1996/012516 external-priority patent/WO1998004689A1/en
Application granted granted Critical
Publication of ATE311450T1 publication Critical patent/ATE311450T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96926195T 1996-07-31 1996-07-31 BIOMARKERS AND TARGETS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF PROSTATE CANCER ATE311450T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/012516 WO1998004689A1 (en) 1995-07-31 1996-07-31 Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Publications (1)

Publication Number Publication Date
ATE311450T1 true ATE311450T1 (en) 2005-12-15

Family

ID=22255530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926195T ATE311450T1 (en) 1996-07-31 1996-07-31 BIOMARKERS AND TARGETS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF PROSTATE CANCER

Country Status (3)

Country Link
AT (1) ATE311450T1 (en)
AU (1) AU712403B2 (en)
DE (1) DE69635526T2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113633B (en) * 2021-12-27 2024-05-24 复旦大学 Molecular index and kit for diagnosing risk and evaluating curative effect of prostate cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262311A (en) * 1992-03-11 1993-11-16 Dana-Farber Cancer Institute, Inc. Methods to clone polyA mRNA
US5639656A (en) * 1994-03-31 1997-06-17 Medical College Of Hampton Road Antibodies reactive with biological markers of benign prostate hyperplasia
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
DE69635526T2 (en) 2006-08-17
DE69635526D1 (en) 2006-01-05
AU712403B2 (en) 1999-11-04
AU6642996A (en) 1998-02-20

Similar Documents

Publication Publication Date Title
AU4560499A (en) Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
ATE261517T1 (en) COUPLING FOR AN EXCAVATOR TOOTH OR THE LIKE.
EP1090291A4 (en) Method for early diagnosis of, and determination of prognosis in, cancer
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
DE69813198D1 (en) Inner lining for hanshoe
CA2137822A1 (en) Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes
MXPA01008794A (en) Method of diagnosing and monitoring malignant breast carcinomas.
DE59910983D1 (en) Authentication system for PC cards
DE69506294T2 (en) Fluorescent indicators for sludge dewatering
DE69932772D1 (en) Analysis system for radio environment
DE806667T1 (en) Immunoassay for H. pylori in faecal samples
DE69933633D1 (en) Drive for vehicles
EP1080227A4 (en) A novel method of diagnosing, monitoring, and staging colon cancer
DE69841213D1 (en) Subsequent estimate for phase-modulated signals
WO2001037779A3 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
ATE311450T1 (en) BIOMARKERS AND TARGETS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF PROSTATE CANCER
DE69904411T2 (en) Window antenna for an automobile
DE59814379D1 (en) TUMORVAKZINE FOR MUC1-POSITIVE CARCINOMA
DE59800796D1 (en) DRIVE ARRANGEMENT, ESPECIALLY FOR OMNIBUSES
DE69933754D1 (en) PLANET TRANSMISSION SYSTEM FOR DOUBLE-SIDED LAPTOP MACHINE
BR9900071B1 (en) probe for cast metal.
DE68907917T2 (en) HINGE FOR TURNTABLE WINDOWS, ESPECIALLY SLOPED ROOF WINDOWS.
EP1115426A4 (en) Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
DE29712099U1 (en) Lining for manholes
DE68907916T2 (en) HINGE FOR TURNTABLE WINDOWS, ESPECIALLY SLOPED ROOF WINDOWS.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties